Synapse
⌘+K
Synapse
PulseExploreClubsResearchersJournals
Instagram
HomeClubsExplore
June 20, 2003American Journal of HematologyOpen Access

Busulfan, cyclophosphamide, and etoposide as conditioning for autologous stem cell transplantation in multiple myeloma

View Full Paper
Ask AI
Bookmark
Share

Authors

CCChristopher R. CogleChristophorus KlinikenJMJan S. MorebUniversity of MaryHLHelen LeatherUniversity of Florida

Discussion

Loading...

Member takes

Overview

Key Points

Key points are not available for this paper at this time.

Cite This Study

Cogle et al. (2003) studied this question.

synapsesocial.com/papers/6a1fabece47f012c48075743https://doi.org/10.1002/ajh.10342
View Full Paper
Ask AI
Bookmark
Share

Also Consider

Synapse has enriched 2 closely related papers on similar clinical questions. Consider them for comparative context:

  1. 1High dose etoposide-based myeloablative therapy followed by autologous blood progenitor cell rescue in the treatment of multiple myeloma1996 · 14 citations
  2. 2Nonparametric Estimation from Incomplete Observations1958 · 39,539 citations